Evidence map›Paper›PMID 29085011›Full record

ArticleScientific reports2017

Highly Sensitive Plasmonic Detection of the Pancreatic Cancer Biomarker CA 19-9.

Zaynab A R Jawad, Ioannis G Theodorou, Long R Jiao, Fang Xie

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Exploiting the relevance of CA 19-9 in pancreatic cancer.Journal of cancer metastasis and treatment · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zaynab A R JawadDepartment of Materials and London Centre for Nanotechnology, Imperial College London, SW7 2AZ, London, UK.
Ioannis G TheodorouDepartment of Materials and London Centre for Nanotechnology, Imperial College London, SW7 2AZ, London, UK.ORCID 0000-0002-9572-417X
Long R JiaoDepartment of Cancer and Surgery, Imperial College London, SW12 0HS, London, UK.
Fang XieDepartment of Materials and London Centre for Nanotechnology, Imperial College London, SW7 2AZ, London, UK. f.xie@imperial.ac.uk.
London Centre for Nanotechnology · GBImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmonic gold (Au) nanotriangular arrays, functionalized with a near infrared (NIR) fluorophore-conjugated immunoassay to Carbohydrate Antigen 19-9 (CA 19-9), a pancreatic cancer biomarker, produce optically tunable substrates with two orders of magnitude fluorescence enhancement. Through nanoscale morphological control, the sensitivities of the plasmonic nanotriangular arrays are controllable, paving the way of such optical platforms for multiplexing. Here, we report a limit of detection (LOD) of 7.7 × 10

Indexed as

AnimalsBiomarkers, TumorCA-19-9 AntigenEquidaeGoldHumansImmunoassayLimit of DetectionPancreatic NeoplasmsBiomarkers, TumorCA-19-9 AntigenGold

Identifiers

PMID29085011
PMCPMC5662715
OpenAlexW2766457609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.